The generation of B-cell precursors (BCP) from lymphohematopoietic progenitors (LHP) in bone marrow is dependent on signals provided by the receptor tyrosine kinase Flt3 and its ligand, . Mice deficient in FL exhibit striking reductions in LHP and BCP. Currently, the mechanism by which Flt3 regulates lymphoid lineage/B-cell development is unknown. Here, we show that haploinsufficiency of FL (FL 1/À ) reduced the numbers of LHP, common lymphoid progenitors, and pro-B cells, suggesting that FL levels set a threshold for B lymphopoiesis. Limiting dilution analysis confirmed reduced BCP frequency in FL 1/À mice. Real-time PCR of LHP from FL 1/À animals showed increased transcripts of the B lineage inhibitor id1. However, targeted deletion of id1 did not restore the lymphoid/B lineage deficiencies in FL À/À mice, supporting Id1-independent mechanisms. BrdU incorporation studies established that FL is not essential for the proliferation of Flt3 1 multipotential progenitors. Analysis of FL À/À progenitors expressing low levels of Flt3 revealed decreased levels of the pro-survival factor Mcl1. Consequently, the Flt3 1 LHP progeny of Flt3 low LSK 1 cells exhibited increased Annexin V staining. Together, these data suggest that Flt3 signaling initiates a cascade of events in Flt3 low precursors that promote the survival of LHP from which BCP are derived.Key words: Apoptosis . B-cell development . Cell differentiation . Flt3-ligand
IntroductionLymphopoiesis is a stepwise process dependent on signals from the microenvironment. In bone marrow (BM), differentiating multipotential progenitors (MPP) integrate microenvironmental signals to generate lymphoid progenitors from which B-cell precursors (BCP) are derived. Fms-like tyrosine kinase (Flt3) and its ligand, , are critical regulators of lymphoid progenitors and their B lineage progeny. However, the mechanism by which Flt3 signaling regulates the generation of BCP from lymphohematopoietic progenitors (LHP) in vivo is not well understood.HSC and MPP can be identified in BM by a lack of lineage markers (Lin -), expression of stem cell antigen-1 (Sca-1), and high levels of the receptor tyrosine kinase, c-kit [1]. These cells are collectively termed LSK 1 . LHP are Flt3 1 MPP that are functionally distinct from Flt3 À/low MPP in having lost megakaryocyte/erythroid differentiation potential [2]. LHP can be distinguished within MPP by a variety of criteria including GFP knocked into the recombinase-activating gene one (RAG1) coding region [3,4]. LHP defined by these criteria lack surface expression of the IL-7R. Another way to distinguish LHP in vivo is differential expression of Flt3 and VCAM-1 [5]. The ability to distinguish LHP within MPP provides a means to identify and characterize cellular and molecular circuits that regulate lymphoid lineage development.Abundant experimental evidence suggests that the molecular circuitry initiating lymphoid lineage specification within MPP
ResultsHaploinsufficiency of FL reduces LHP and BCP Exogenous administration of FL in vivo increases ...